BERLIN, Germany and ATLANTA, Georgia, September 26, 2023 / B3C newswire / ProBioGen and GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing vaccines and immunotherapies against infectious diseases and cancers, announce the signing of a landmark commercial license agreement for ProBioG.
Fetal Bovine Serum Market Is Predicted To Surpass Usd 1,375 53 Million By 2030: Industry Dynamics And Challenges menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
BOSTON, MA, USA and BERLIN, Germany, May 17, 2023 / B3C newswire / ProBioGen today announced the launch of their lentivirus (LV) packaging cell line Lenti.RiGHT™ as a new platinum standard for LV production at this year's PEGS Boston 2023. The lentivirus production platform is based on HEK293 packaging cells.
BERLIN, Germany, January 18, 2023 / B3C newswire / ProBioGen is announcing another important clinical milestone for its proprietary viral vector and vaccine production cell line AGE1.CRpIX®. Our valued customer Nouscom recently proclaimed that their sub-licensee, has initiated phase 1 clinical trials for VAC85135.
MIMETAS Elected Most Innovative Company of the Netherlands. The award recognizes MIMETA s considerable focus on innovation, contribution to the reduction of animal experimentation, leadership